Simon Mark Walker

Search results

• 2020

  Does Health Technology Assessment guidance give adequate consideration to decisions about less costly and less effective alternatives?

  Griffin, S., Fusco, F., Naidoo, B., Taylor, M. & Walker, S. M., 4 Nov 2020, York, UK: Centre for Health Economics, University of York, 19 p. (CHE Research Paper; no. 175).

  Research output: Working paper

  Open Access

  File
• 2015

  The value of implementation: how to invest in getting cost-effective technologies into practice. Framework and application to novel oral anticoagulants in the prevention of stroke and systemic embolism

  Faria, R., Walker, S. M., Whyte, S., Dixon, S., Palmer, S. J. & Sculpher, M., 2015, (Unpublished).

  Research output: Working paper

• 2014

  Using cost-effectiveness thresholds to determine value for money in low-and middle-income country healthcare systems: Are current international norms fit for purpose?

  Revill, P., Walker, S. M., Madan, J., Ciaranello, A., Mwase, T., Gibb, D. M., Claxton, K. P. & Sculpher, M. J., 2014, York, UK: Centre for Health Economics, University of York, 15 p. (CHE Research Paper ; no. 98).

  Research output: Working paper

  Open Access

  File
• 2009

  Cetuximab plus radiotherapy for the treatment of locally advance squamous cell carcinmoa of the head and neck

  Griffin, S., Walker, S. & Sculpher, M., 2009.

  Research output: Working paper

• 2008

  The GMS quality and outcomes framework: Are the quality and outcomes framework (QOF) indicators a cost-effective use of NHS resources?

  Mason, A., Walker, S., Claxton, K., Cookson, R., Fenwick, E. & Sculpher, M., 2008.

  Research output: Working paper